Cart
sales@molnova.com
TAS6417
CAS No. 1661854-97-2
TAS6417 ( —— )
Catalog No. M23746 CAS No. 1661854-97-2
TAS6417 is an EGFR inhibitor and is an efficacious drug candidate for patients with NSCLC.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 178 | In Stock |
|
| 10MG | 295 | In Stock |
|
| 25MG | 597 | In Stock |
|
| 50MG | 954 | In Stock |
|
| 100MG | 1467 | In Stock |
|
| 500MG | 2952 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTAS6417
-
NoteResearch use only, not for human use.
-
Brief DescriptionTAS6417 is an EGFR inhibitor and is an efficacious drug candidate for patients with NSCLC.
-
DescriptionTAS6417 is an EGFR inhibitor and is an efficacious drug candidate for patients with NSCLC (IC50: ranging from 1.1-8.0 nM).
-
Synonyms——
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorApoptosis;EGFR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1661854-97-2
-
Formula Weight396.4
-
Molecular FormulaC23H20N6O
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL (315.31 mM)
-
SMILESCC1=C[C@@H](CN2C1=C(C3=C(N=CN=C32)N)C4=CC5=CC=CC=C5N=C4)NC(=O)C=C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hasako S, et al. TAS6417, A Novel EGFR Inhibitor Targeting Exon 20 Insertion Mutations. Mol Cancer Ther. 2018 Aug;17(8):1648-1658.
molnova catalog
related products
-
Mepazine
Mepazine is a potent and selective inhibitor of MALT1. Mepazine inhibits GSTMALT1 full length and GSTMALT1 325-760 with IC50s of 0.83 μM and 0.42 μM.
-
WM-3835
WM-3835 is a novel and high-specific small molecule?inhibitor of Lysine Acetyltransferase 7 (KAT7, MYST2, HBO1)?, able to potently suppressed OS cell proliferation and migration, and leads to?apoptosis?activation.
-
Flurochloridone
Flurochloridone is a selective herbicide. Flurochloridone induces apoptosis and is regulated by mitochondrial dysfunction and oxidative stresses.
